Characteristics | All (n = 319) | Ankylosing spondylitis (n = 153) | Psoriatic arthritis (n = 166) | |||
---|---|---|---|---|---|---|
Metabolic syndrome | Metabolic syndrome | Metabolic syndrome | ||||
Yes (n = 101) | No (n = 218) | Yes (n = 29) | No (n = 124) | Yes (n = 72) | No (n = 94) | |
Number of MetS criteria, median (IQR) | 4.0 (1.0) | 1.0 (2.0)* | 4.0 (1.0) | 1.0 (2.0)* | 3.5 (1.0) | 1.0(2.0)* |
Elevated WC, n (%) | 93 (92.1%) | 60 (27.5%)* | 24 (82.8%) | 34 (27.4%)* | 69 (95.8%) | 26 (27.7%)* |
Elevated BP, n (%) | 87 (86.1%) | 55 (25.2%)* | 24 (82.8%) | 28 (22.6%)* | 63 (87.5%) | 27 (28.7%)* |
Elevated FG, n (%) | 74 (73.3%) | 38 (17.4%)* | 23 (79.3%) | 13 (10.5%)* | 51 (70.8%) | 25 (26.6%)* |
Elevated TG, n (%) | 50 (49.5%) | 20 (9.2%)* | 12 (41.4%) | 12 (9.7%)* | 38 (52.8%) | 8 (8.5%)* |
Reduced HDL-C, n (%) | 63 (62.4%) | 26 (11.9%)* | 21 (72.4%) | 12(9.7%)* | 42 (58.3%) | 14 (14.9%)* |
Age (yrs), mean ± SD | 52.3 ± 10.1 | 42.3 ± 11.9* | 48.0 ± 9.2 | 40.3 ± 11.2* | 54.0 ± 9.9 | 45.1 ± 12.3* |
Female gender, n (%) | 55 (54.5%) | 93 (42.7%)* | 8 (27.6%) | 51 (41.1%) | 47 (65.3%) | 42 (44.7%)* |
History of smoking, n (%) | 13 (12.9%) | 42 (19.3%) | 4 (13.8%) | 18 (14.5%) | 9 (12.5%) | 24 (25.5%)* |
Current smoker, n (%) | 5 (5.0%) | 22 (10.1%) | 3 (10.3%) | 9 (7.3%) | 2 (2.8%) | 13 (13.8%)* |
Current exercise, n (%) | 40 (39.6%) | 94 (43.1%) | 9 (31.0%) | 40 (49.2%) | 31 (43.1%) | 33 (35.1%) |
Physical work, n (%) | 37 (36.6%) | 85 (39.0%) | 8 (27.6%) | 41 (33.1%) | 29 (40.3%) | 44 (46.8%) |
BMI (kg/m2), mean ± SD | 27.2 ± 6.0 | 23.1 ± 4.5* | 27.0 ± 4.5 | 22.5 ± 4.6* | 27.3 ± 4.5 | 23.7 ± 4.3* |
Disease duration (yrs), median (IQR) | 5.0 (8.0) | 5.0 (9.0) | 10.0(14.5) | 10(13.8) | 3.0(6.5) | 3.0(4.6) |
ASDAS-CRP, mean (SD) | 2.0 (1.1) | 2.2 (1.1) | 2.0 (1.1) | 2.2(1.1) | 2.0 (1.1) | 2.3 (1.2) |
DAPSA, median (IQR) | N/A | N/A | N/A | N/A | 6.3 (10.5) | 9.1 (12) |
cDAPSA, median (IQR) | N/A | N/A | N/A | N/A | 6.0(9.5) | 8.0 (11) |
No. of SynAnk, median (IQR) | 5.5 (8.0) | 2.0 (7.0)* | 5.0 (11.5) | 2.0 (10.0)* | 6.0 (9.0) | 2.0 (5.0)* |
Current DMARDs, median (IQR) | 1.0 (1.5) | 1.0 (0) | 1.0 (1.5) | 1.0 (1.0) | 1.0 (1.0) | 1.0 (0.25) |
Current NSAIDs, n (%) | 34 (33.7%) | 81 (37.2%) | 12 (41.3%) | 53 (42.7%) | 22 (30.6%) | 28 (29.8%) |